Oxiracetam is a nootropic drug of the racetam family, utilized clinically to treat cognitive impairments, cerebrovascular disorders, and multi-infarct dementia by enhancing neurotransmitter activity. Analytical… Read more








Oxiracetam is a nootropic drug of the racetam family, utilized clinically to treat cognitive impairments, cerebrovascular disorders, and multi-infarct dementia by enhancing neurotransmitter activity. Analytical laboratories rely on high-quality reference standards of oxiracetam to support comprehensive pharmaceutical testing, including impurity profiling and method validation. This collection encompasses essential materials for rigorous quality control, such as pharmacopeial and non-pharmacopeial impurities, specific stereoisomers, and stable isotope labelled compounds. Using these chemically pure standards, researchers and analysts can accurately identify and quantify degradation products and synthetic by-products within complex matrices. Stable isotope labelled oxiracetam is particularly valuable as an internal standard in mass spectrometry-based assays, ensuring precision and reliability in quantitative bioanalytical procedures during the development and ongoing monitoring of this cognitive enhancer.